marijuana stock news

Tetra Bio-Pharma Inc. Clarifies AGM Meeting Location

Tetra Bio-Pharma Inc. (“Tetra” or the “Corporation”) (TSX VENTURE:TBP) (TBPMF), wishes to clarify that the annual general meeting of shareholders of the Corporation (the “Meeting”) is to be held in the City of Montréal, Québec. The Corporation noted that the notice of meeting and record date filed under the Corporation’s profile on SEDAR on April 27, 2018 incorrectly stated that the Meeting would be held in the City of Ottawa, Ontario. The time and date of the Meeting are unchanged and it is scheduled to be held on June 19, at 2:00 p.m.

The Meeting will be held at the offices of Stikeman Elliott LLP located at:

1155, René-Lévesque Boulevard West,
Montréal, Québec,
H3B 3V2

Shareholders as of the record date of May 15, 2018, will receive an information circular and proxy voting instruction form by mail in advance of the Meeting.

The Corporation has filed an amended notice of meeting and record date on SEDAR and shareholders will be able to download the amended notice of meeting and record date.

The Corporation apologizes for any confusion.

About Tetra Bio-Pharma:
Tetra Bio-Pharma (TBP.V) (TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a clinical program aimed at bringing novel drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries that are engaged in the development of Bio Pharmaceuticals and Natural Health Products containing cannabis and other medicinal plant-based elements. Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.

More information at: www.tetrabiopharma.com
Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a license for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
More information at: www.tetrabiopharma.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$DIRV 2015 Texas Emergency Management and Homeland Security Conference

DirectView Security to Attend the 2015 Texas Emergency Management and Homeland Security…

Hemp, Inc. (HEMP) Expands Joint Venture Agreement with HQ Global Education, Inc.

Hemp, Inc. Expands Joint Venture Agreement with HQ Global Education, Inc. to…

$MYEC Signs Reseller agreement with Leading Innovator Maverick Bankcard

GreenPay Signs Reseller Agreement with Maverick Bankcard FOLSOM, Calif., Nov. 5, 2014…

22nd Century Group, Inc. (XXII) to Announce Second Quarter 2023 Results on August 14, 2023

22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2023 Results on…